"Meander Medisch Centrum is een topklinisch ziekenhuis voor de regio Amersfoort. De hoofdlocatie is Amersfoort. In Baarn zit een kleine locatie waar vooral poliklinische zorg wordt verleend. Verder heeft Meander buitenlocaties voor diagnostiek en/of poliklinische zorg in Barneveld, Bunschoten-Spakenburg, Leusden en Nijkerk."

During the past decade, Meander Medisch Centrum conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 10 clinical trials were completed, i.e. on average, 11.4% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 4 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meander Medisch Centrum" #1 sponsor was "UMC Utrecht" with 14 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 11 trials sponsored, "Meander Medical Center" with 8 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 6 trials sponsored and "The Netherlands Cancer Institute" with 6 trials sponsored. Other sponsors include 85 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meander Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 13 trials as a collaborator, "UMC Utrecht" with 5 trials as a collaborator, "Amsterdam UMC, location VUmc" with 4 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 162 different institutions and companies that were collaborators in the rest 146 trials.

According to Clinical.Site data, the most researched conditions in "Meander Medisch Centrum" are "Colorectal Cancer" (6 trials), "Heart Failure" (4 trials), "Lymphoma" (4 trials), "Acute Coronary Syndrome" (3 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "Meander Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Meander Medisch Centrum" are "Drug" (77 trials), "Procedure" (19 trials), "Other" (15 trials), "Biological" (10 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "filgrastim" (4 trials), "Atezolizumab" (3 trials), "Bevacizumab" (3 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Meander Medisch Centrum" are 123 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 61 active trials in "Meander Medisch Centrum". 2 are not yet recruiting, 35 are recruiting, 22 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 44 completed trials in Meander Medisch Centrum, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Meander Medisch Centrum, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 33 trials that are defined as “Not Applicable".